NSB
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
$0.0620
0.00%
Market cap
$24M
Turnover
$4,355
Last price
$0.0620
Day change
0.00%
Announcements
7
Range, past year
Open 0.165 · Low 0.047 · Now 0.062 · High 0.260
Open NSB in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
NSB momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
29/100
Wyckoff phase
Accumulation1d
Trend stage
Neutral
1 Day
+0.0%
1 Week
-4.6%
1 Month
+0.0%
1 Year
-62.4%
RSI
50
Avg daily range
5.0%
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD scores 29 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 1 trading day. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -21.1%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
NSB announcements
Recent price-sensitive releases.
- 2026-08-25 2026 Annual Report & Appendix 4E Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-28 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-05-26 Remarkable Results from Patients treated with StemSmart
- 2026-05-25 Trading Halt
- 2026-04-30 Quarterly Activities/Appendix 4C Cash Flow Report
More Health Care stocks
Most traded in the same sector.